Latest Insider Transactions at Orasure Technologies Inc (OSUR)
This section provides a real-time view of insider transactions for Orasure Technologies Inc (OSUR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ORASURE TECHNOLOGIES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ORASURE TECHNOLOGIES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 05
2022
|
James A Datin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,110
-1.87%
|
$3,330
$3.96 P/Share
|
|
Oct 05
2022
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,098
+6.46%
|
$12,294
$3.96 P/Share
|
|
Aug 26
2022
|
Ronny B Lancaster Director |
BUY
Open market or private purchase
|
Direct |
50,000
+32.3%
|
$200,000
$4.0 P/Share
|
|
Aug 25
2022
|
Mara G. Aspinall Director |
BUY
Open market or private purchase
|
Direct |
6,000
+7.21%
|
$24,000
$4.19 P/Share
|
|
Aug 17
2022
|
Nancy J Gagliano Director |
BUY
Open market or private purchase
|
Direct |
2,200
+4.96%
|
$8,800
$4.39 P/Share
|
|
Aug 12
2022
|
Michael Celano Director |
BUY
Open market or private purchase
|
Direct |
12,000
+9.69%
|
$48,000
$4.49 P/Share
|
|
Aug 08
2022
|
Kenneth J Mc Grath Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
131,883
+50.0%
|
$395,649
$3.03 P/Share
|
|
Jun 27
2022
|
James A Datin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,523
-2.68%
|
$3,046
$2.89 P/Share
|
|
Jun 27
2022
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,623
+9.02%
|
$11,246
$2.89 P/Share
|
|
Jun 16
2022
|
Nancy J Gagliano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,841
-4.45%
|
$23,364
$4.69 P/Share
|
|
Jun 04
2022
|
Manner Carrie Eglinton President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,140,762
+36.11%
|
$4,563,048
$4.91 P/Share
|
|
Jun 03
2022
|
Mara G. Aspinall Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,745
-8.65%
|
$26,980
$4.0 P/Share
|
|
Jun 03
2022
|
Mara G. Aspinall Director |
SELL
Grant, award, or other acquisition
|
Direct |
24,983
-24.27%
|
$99,932
$4.0 P/Share
|
|
Jun 01
2022
|
Lelio Marmora Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,104
-6.37%
|
$8,416
$4.12 P/Share
|
|
May 21
2022
|
Scott Gleason Interim CFO/SVP IR |
SELL
Payment of exercise price or tax liability
|
Direct |
1,996
-2.03%
|
$9,980
$5.53 P/Share
|
|
May 16
2022
|
Michael Celano Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,762
+19.88%
|
$123,810
$5.25 P/Share
|
|
May 16
2022
|
Michael Celano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,399
-4.33%
|
$16,995
$5.25 P/Share
|
|
May 16
2022
|
Ronny B Lancaster Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+26.74%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
David Shulkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+39.56%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
David Shulkin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,745
-20.65%
|
$13,725
$5.25 P/Share
|
|
May 16
2022
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.13%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Eamonn P Hobbs Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+24.55%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Eamonn P Hobbs Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,409
-5.49%
|
$12,045
$5.25 P/Share
|
|
May 16
2022
|
Mara G. Aspinall Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+27.4%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Mara G. Aspinall Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,957
-8.23%
|
$14,785
$5.25 P/Share
|
|
May 16
2022
|
Lelio Marmora Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+37.71%
|
$100,000
$5.25 P/Share
|
|
May 16
2022
|
Lelio Marmora Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,928
-27.43%
|
$24,640
$5.25 P/Share
|
|
May 16
2022
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+39.55%
|
$100,000
$5.25 P/Share
|
|
May 11
2022
|
Lisa Nibauer President of Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,606
-1.28%
|
$8,030
$5.05 P/Share
|
|
Apr 06
2022
|
David Shulkin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,247
-14.46%
|
$13,482
$6.71 P/Share
|
|
Apr 01
2022
|
Nancy J Gagliano Director |
BUY
Grant, award, or other acquisition
|
Direct |
114,074
+41.04%
|
-
|
|
Apr 01
2022
|
Nancy J Gagliano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,392
-17.31%
|
$26,352
$6.75 P/Share
|
|
Mar 25
2022
|
James A Datin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
636
-2.0%
|
$3,816
$6.92 P/Share
|
|
Mar 25
2022
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,349
+6.89%
|
$14,094
$6.92 P/Share
|
|
Feb 01
2022
|
Agnieszka Gallagher General Counsel & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
38,050
+29.58%
|
$304,400
$8.86 P/Share
|
|
Feb 01
2022
|
Stephen S Phd Tang President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,321
-2.69%
|
$242,568
$8.86 P/Share
|
|
Feb 01
2022
|
Stephen S Phd Tang President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
119,913
+14.32%
|
$959,304
$8.86 P/Share
|
|
Feb 01
2022
|
Lisa Nibauer President of Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
34,556
+21.65%
|
$276,448
$8.86 P/Share
|
|
Feb 01
2022
|
Lisa Nibauer President of Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,606
-2.8%
|
$20,848
$8.86 P/Share
|
|
Feb 01
2022
|
Michele Marie Miller SVP Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
6,772
+9.49%
|
$54,176
$8.86 P/Share
|
|
Feb 01
2022
|
Michele Marie Miller SVP Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,662
-0.94%
|
$13,296
$8.86 P/Share
|
|
Feb 01
2022
|
Kathleen Gallagher Weber Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,526
-1.31%
|
$76,208
$8.86 P/Share
|
|
Feb 01
2022
|
Kathleen Gallagher Weber Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,050
+8.84%
|
$328,400
$8.86 P/Share
|
|
Feb 01
2022
|
Scott Gleason Interim CFO/SVP IR |
BUY
Grant, award, or other acquisition
|
Direct |
29,345
+22.95%
|
$234,760
$8.86 P/Share
|
|
Jan 05
2022
|
Lisa Nibauer President of Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
60,901
+39.54%
|
$487,208
$8.21 P/Share
|
|
Jan 05
2022
|
Kathleen Gallagher Weber Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,901
+25.87%
|
$487,208
$8.21 P/Share
|
|
Jan 05
2022
|
Michele Marie Miller SVP Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
42,631
+41.74%
|
$341,048
$8.21 P/Share
|
|
Jan 05
2022
|
Scott Gleason Interim CFO/SVP IR |
BUY
Grant, award, or other acquisition
|
Direct |
48,721
+41.33%
|
$389,768
$8.21 P/Share
|
|
Dec 31
2021
|
Jack E Jerrett SVP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,320
-4.89%
|
$162,560
$8.81 P/Share
|
|
Dec 22
2021
|
James A Datin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,717
+5.52%
|
$15,453
$9.46 P/Share
|